The opposing trends of body mass index and blood pressure during 1977-2020; nationwide registry of 2.8 million male and female adolescents.
Adolescents
Body Mass Index
Diastolic blood pressure
Hypertension
Obesity
Systolic blood pressure
Journal
Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637
Informations de publication
Date de publication:
28 12 2021
28 12 2021
Historique:
received:
25
10
2021
accepted:
10
12
2021
entrez:
29
12
2021
pubmed:
30
12
2021
medline:
22
2
2022
Statut:
epublish
Résumé
Elevated blood pressure among adolescents has been shown to be associated with future adverse cardiovascular outcomes and early onset diabetes. Most data regarding systolic and diastolic blood pressure trends are based on surveys of selected populations within 10-20-year periods. The goal of this study was to characterize the secular trend of blood pressure given the rising prevalence of adolescent obesity. This nationwide population-based study included 2,785,515 Israeli adolescents (41.6% females, mean age 17.4 years) who were medically evaluated and whose weight, height and blood pressure were measured, prior to mandatory military service between 1977 and 2020. The study period was divided into 5-year intervals. Linear regression models were used to describe the P for trend along the time intervals. Analysis of covariance was used to calculate means of blood pressure adjusted for body mass index. During the study period, the mean body mass index increased by 2.1 and 1.6 kg/m Despite the increase in body mass index over the last four decades, diastolic blood pressure decreased in both sexes while systolic blood pressure increased slightly in males and decreased in females.
Sections du résumé
BACKGROUND
Elevated blood pressure among adolescents has been shown to be associated with future adverse cardiovascular outcomes and early onset diabetes. Most data regarding systolic and diastolic blood pressure trends are based on surveys of selected populations within 10-20-year periods. The goal of this study was to characterize the secular trend of blood pressure given the rising prevalence of adolescent obesity.
METHODS
This nationwide population-based study included 2,785,515 Israeli adolescents (41.6% females, mean age 17.4 years) who were medically evaluated and whose weight, height and blood pressure were measured, prior to mandatory military service between 1977 and 2020. The study period was divided into 5-year intervals. Linear regression models were used to describe the P for trend along the time intervals. Analysis of covariance was used to calculate means of blood pressure adjusted for body mass index.
RESULTS
During the study period, the mean body mass index increased by 2.1 and 1.6 kg/m
CONCLUSION
Despite the increase in body mass index over the last four decades, diastolic blood pressure decreased in both sexes while systolic blood pressure increased slightly in males and decreased in females.
Identifiants
pubmed: 34963457
doi: 10.1186/s12933-021-01433-0
pii: 10.1186/s12933-021-01433-0
pmc: PMC8715587
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
242Informations de copyright
© 2021. The Author(s).
Références
Cardiovasc Diabetol. 2021 Mar 24;20(1):70
pubmed: 33761942
Cardiovasc Diabetol. 2016 May 05;15:74
pubmed: 27151384
Vital Health Stat 11. 2002 May;(246):1-190
pubmed: 12043359
J Pediatr. 2015 Dec;167(6):1422-8.e2
pubmed: 26342719
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
J Epidemiol. 2012;22(5):448-53
pubmed: 22863986
J Clin Pharmacol. 2016 Jan;56(1):78-86
pubmed: 26073563
Int J Hypertens. 2021 Jul 15;2021:6646868
pubmed: 34327015
Int J Obes (Lond). 2019 Jul;43(7):1391-1399
pubmed: 30258119
JAMA. 2016 Jun 7;315(21):2292-9
pubmed: 27272581
Am J Hypertens. 2016 Feb;29(2):217-25
pubmed: 26158854
J Am Heart Assoc. 2020 Aug 18;9(16):e016405
pubmed: 32779511
Nature. 2010 Jul 8;466(7303):238-42
pubmed: 20531471
Pediatrics. 2012 Jul;130(1):e159-66
pubmed: 22665416
J Hypertens. 2016 Oct;34(10):1948-58
pubmed: 27467766
Prev Med. 2011 Mar-Apr;52(3-4):213-7
pubmed: 21334371
Lancet. 2011 Feb 12;377(9765):557-67
pubmed: 21295846
J Clin Hypertens (Greenwich). 2017 May;19(5):488-497
pubmed: 27982505
J Clin Endocrinol Metab. 2001 Sep;86(9):4061-7
pubmed: 11549626
JAMA Pediatr. 2019 Dec 1;173(12):1154-1163
pubmed: 31589252
J Clin Endocrinol Metab. 2021 Mar 25;106(4):978-987
pubmed: 33449080
JAMA Netw Open. 2020 Dec 1;3(12):e2027465
pubmed: 33263760
J Am Coll Cardiol. 2011 Nov 29;58(23):2396-403
pubmed: 22115646
Cardiovasc Diabetol. 2016 May 03;15:73
pubmed: 27141948
Cardiovasc Diabetol. 2020 Jun 13;19(1):79
pubmed: 32534575
Cardiovasc Diabetol. 2021 Mar 22;20(1):68
pubmed: 33752666
Pediatrics. 2001 Dec;108(6):E108
pubmed: 11731635
BMJ Open. 2013 Dec 23;3(12):e003733
pubmed: 24366578
Hum Genet. 2013 Feb;132(2):119-27
pubmed: 23052947
JAMA Intern Med. 2019 Apr 1;179(4):517-523
pubmed: 30801616
Nat Rev Nephrol. 2017 Jan;13(1):2
pubmed: 27916976
N Engl J Med. 2015 Oct;373(14):1307-17
pubmed: 26422721
Cardiovasc Diabetol. 2020 May 12;19(1):60
pubmed: 32398003
JAMA Netw Open. 2021 Apr 1;4(4):e213917
pubmed: 33792732
Am J Clin Nutr. 2010 Nov;92(5):1172-80
pubmed: 20826631
Cardiovasc Diabetol. 2015 May 21;14:58
pubmed: 25990248
BMJ. 2004 Jul 17;329(7458):139
pubmed: 15226191
Diabetes Care. 2021 Jan;44(1):e6-e8
pubmed: 33148634
Cardiovasc Diabetol. 2020 Oct 6;19(1):168
pubmed: 33023586
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3426-e3435
pubmed: 34050759
Cardiovasc Diabetol. 2018 Jun 5;17(1):80
pubmed: 29871640
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
Cardiovasc Diabetol. 2019 Sep 25;18(1):124
pubmed: 31554505
Cardiovasc Diabetol. 2016 Jan 20;15:9
pubmed: 26790404
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e34-e44
pubmed: 33075820
Am J Hypertens. 2020 Feb 22;33(2):175-181
pubmed: 31777921
Hypertension. 2019 Dec;74(6):1316-1323
pubmed: 31630574
Circulation. 2011 Jul 26;124(4):397-405
pubmed: 21730305